tiprankstipranks

Lawrence Kenyon Insider Profile

4 Followers
Lawrence Kenyon, CFO & Sec at Insys Therapeutics, holds 0.00 shares in Insys Therapeutics (Ticker: INSYQ), holds 5.95K shares in Outlook Therapeutics (Ticker: OTLK), holds 93.48K shares in Oncobiologics Inc (Ticker: ONSIU). Most recently, Lawrence Kenyon ― shares of Insys Therapeutics on ― for an estimated value of ―.
tipranks
Lawrence Kenyon

Lawrence Kenyon
Insys Therapeutics (INSYQ)
CFO & Sec

Ranked #73,182 out of 99,335 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

-22.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$31K
100.00%
A breakdown of Lawrence Kenyon's holdings

Insider Roles

Outlook Therapeutics
(OTLK)
CFO, Director
Roles that Lawrence Kenyon holds in companies

Most Profitable Insider Trade

Stock:
Outlook Therapeutics
(OTLK)
Rating:Informative Buy
Date:Sep 30, 2024 - Today
Return:+18.30%
The most profitable trade made by Lawrence Kenyon

Lawrence Kenyon's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
INSYQ
Insys Therapeutics
$0.00
ONSIU
Oncobiologics Inc
Dec 22, 2016
Uninformative Buy
$441.22K
Outlook Therapeutics
Sep 30, 2024
CFO, Director
Informative Buy
28.40K
$31.10K
PRX
Par Pharmaceutical Cos. Inc.
Aug 04, 2010
Uninformative Sell
169.79K
List of latest transactions for each holding click on a transaction to see Lawrence Kenyon's performance on stock

Lawrence Kenyon insider profile FAQ

What is the percentage of profitable transactions made by Lawrence Kenyon?
The percentage of profitable transactions made by Lawrence Kenyon is 67%.
    What is the average return per transaction made by Lawrence Kenyon?
    The average return per transaction made by Lawrence Kenyon is -22.20%.
      What stocks does Lawrence Kenyon hold?
      Lawrence Kenyon holds: INSYQ, ONSIU, OTLK, PRX stocks.
        What was Lawrence Kenyon’s latest transaction?
        Lawrence Kenyon latest transaction was an Uninformative Buy of ―.
          What was Lawrence Kenyon's most profitable transaction?
          Lawrence Kenyon’s most profitable transaction was an Informative Buy of OTLK stock on September 30, 2024. The return on the trade was 18.30%.
            What is Lawrence Kenyon's role in Insys Therapeutics?
            Lawrence Kenyon's role in Insys Therapeutics is CFO & Sec.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.